Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer.

Tas, Faruk; Bilgin, Elif; Tastekin, Didem; Erturk, Kayhan; Duranyildiz, Derya.

Afiliação

Tas F; Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, Istanbul 34390, Turkey.
Bilgin E; Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, Istanbul 34390, Turkey.
Tastekin D; Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, Istanbul 34390, Turkey.
Erturk K; Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, Istanbul 34390, Turkey.
Duranyildiz D; Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, Istanbul 34390, Turkey.

Biomed Rep ; 4(5): 609-614, 2016 May.

Article em En | MEDLINE | ID: mdl-27123256